rs146868811

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_000719.7(CACNA1C):​c.4122C>T​(p.Tyr1374Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000452 in 1,613,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000031 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.238

Publications

0 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 12-2653882-C-T is Benign according to our data. Variant chr12-2653882-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 381370.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.238 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000184 (28/152304) while in subpopulation AFR AF = 0.000505 (21/41560). AF 95% confidence interval is 0.000338. There are 0 homozygotes in GnomAd4. There are 12 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 28 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.4122C>T p.Tyr1374Tyr synonymous_variant Exon 33 of 47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.4122C>T p.Tyr1374Tyr synonymous_variant Exon 33 of 47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.4122C>T p.Tyr1374Tyr synonymous_variant Exon 33 of 47 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.4122C>T p.Tyr1374Tyr synonymous_variant Exon 33 of 47 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.4356C>T p.Tyr1452Tyr synonymous_variant Exon 35 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.4122C>T p.Tyr1374Tyr synonymous_variant Exon 33 of 48 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.4089C>T p.Tyr1363Tyr synonymous_variant Exon 32 of 47 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.4287C>T p.Tyr1429Tyr synonymous_variant Exon 34 of 48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.4266C>T p.Tyr1422Tyr synonymous_variant Exon 35 of 49 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.4188C>T p.Tyr1396Tyr synonymous_variant Exon 33 of 47 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.4122C>T p.Tyr1374Tyr synonymous_variant Exon 33 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.4122C>T p.Tyr1374Tyr synonymous_variant Exon 33 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.4212C>T p.Tyr1404Tyr synonymous_variant Exon 33 of 47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.4212C>T p.Tyr1404Tyr synonymous_variant Exon 33 of 47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.4212C>T p.Tyr1404Tyr synonymous_variant Exon 33 of 47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.4212C>T p.Tyr1404Tyr synonymous_variant Exon 33 of 47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.4206C>T p.Tyr1402Tyr synonymous_variant Exon 34 of 48 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.4197C>T p.Tyr1399Tyr synonymous_variant Exon 34 of 48 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.4182C>T p.Tyr1394Tyr synonymous_variant Exon 34 of 48 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.4122C>T p.Tyr1374Tyr synonymous_variant Exon 33 of 47 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.4122C>T p.Tyr1374Tyr synonymous_variant Exon 33 of 47 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.4122C>T p.Tyr1374Tyr synonymous_variant Exon 33 of 47 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.4173C>T p.Tyr1391Tyr synonymous_variant Exon 33 of 47 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.4164C>T p.Tyr1388Tyr synonymous_variant Exon 33 of 47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.4089C>T p.Tyr1363Tyr synonymous_variant Exon 32 of 46 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.4089C>T p.Tyr1363Tyr synonymous_variant Exon 32 of 46 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.4083C>T p.Tyr1361Tyr synonymous_variant Exon 32 of 46 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.4122C>T p.Tyr1374Tyr synonymous_variant Exon 33 of 47 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.4122C>T p.Tyr1374Tyr synonymous_variant Exon 33 of 47 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.4122C>T p.Tyr1374Tyr synonymous_variant Exon 33 of 47 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.4122C>T p.Tyr1374Tyr synonymous_variant Exon 33 of 47 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.4122C>T p.Tyr1374Tyr synonymous_variant Exon 33 of 47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.4113C>T p.Tyr1371Tyr synonymous_variant Exon 33 of 47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.4089C>T p.Tyr1363Tyr synonymous_variant Exon 32 of 46 ENSP00000507309.1 Q13936-19

Frequencies

GnomAD3 genomes
AF:
0.000177
AC:
27
AN:
152184
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.0000603
AC:
15
AN:
248802
AF XY:
0.0000370
show subpopulations
Gnomad AFR exome
AF:
0.000905
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.0000308
AC:
45
AN:
1461574
Hom.:
0
Cov.:
30
AF XY:
0.0000261
AC XY:
19
AN XY:
727066
show subpopulations
African (AFR)
AF:
0.000568
AC:
19
AN:
33480
American (AMR)
AF:
0.0000447
AC:
2
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53326
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000144
AC:
16
AN:
1111816
Other (OTH)
AF:
0.000116
AC:
7
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000184
AC:
28
AN:
152304
Hom.:
0
Cov.:
33
AF XY:
0.000161
AC XY:
12
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.000505
AC:
21
AN:
41560
American (AMR)
AF:
0.000196
AC:
3
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68028
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000115
Hom.:
0
Bravo
AF:
0.000147

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 12, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 29, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Long QT syndrome Benign:1
Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jul 19, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.31
CADD
Benign
7.9
DANN
Benign
0.50
PhyloP100
-0.24
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146868811; hg19: chr12-2763048; COSMIC: COSV59784603; COSMIC: COSV59784603; API